PT-141 (Bremelanotide) 10mg

$45.00

VOLUME DISCOUNTS

4% off

2 vials

7% off

3 vials

10% off

4+ vials

PT-141 (Bremelanotide) 10mg PT-141, also known as bremelanotide, is a synthetic melanocortin receptor agonist studied in controlled laboratory models involving neuroendocrine signaling and melanocortin pathway activity.

Researchers investigate PT-141 for its relevance in receptor-binding studies, central signaling pathways, and melanocortin system research.

RESEARCH USE ONLY

This product is intended strictly for research and laboratory use only. Not for human consumption, medical use, or diagnostic purposes.

PT-141 (Bremelanotide) 10mg PT-141, also known as bremelanotide, is a synthetic melanocortin receptor agonist studied in controlled laboratory models involving neuroendocrine signaling and melanocortin pathway activity.

Researchers investigate PT-141 for its relevance in receptor-binding studies, central signaling pathways, and melanocortin system research.

Why Researchers Choose PT-141 (Bremelanotide)

Melanocortin Receptor Research

PT-141 is evaluated in models involving melanocortin receptor activity, receptor selectivity, and pathway-specific signaling.

Neuroendocrine Signaling Models

Researchers study PT-141 in controlled systems examining central nervous system signaling and neuroendocrine response markers.

Peptide Receptor Interaction Studies

Used in laboratory research focused on peptide-receptor interactions, signaling cascades, and receptor-mediated biochemical outcomes.

Pre-Clinical Research Utility

Relevant for non-clinical experimental models involving melanocortin biology and central regulatory pathways.

IMPORTANT NOTICE

All compounds are sold individually and do not include research supplies. Products are provided in lyophilized (powder) form and require proper reconstitution before use in research settings.

Shopping Cart
Scroll to Top